1st Quarter - Report · 2026

Filing UUID: fe58fbc7-aae1-4033-a877-2e00f4a31dcd
Type: Q1 — 1st Quarter - Report
Period: first_quarter
Year: 2026
Posted: 2026-04-10 14:25:54
Income (reported): $20,000
Expenses (reported): —
Filing document: Open on lda.senate.gov

Registrant (lobbying firm)

HOLLAND & KNIGHT LLP

Law Firm

Contact: RICHARD GOLD
Phone: +1 202-955-3000
Address: zip:20006, city:Washington, state:DC, street:800 17th Street NW Suite 1100

Client

ACADIA PHARMACEUTICALS INC.

Biopharmaceutical company

State: CA
Country: US
Effective date: 2024-11-12

Issues lobbied + lobbyists

`TAX` — Taxation/Internal Revenue Code

Tax Reform - Restoring the Orphan Drug Tax Credit.

Lobbyists: mr JOSHUA DAVID ODINTZ; mr ANDREW JOSEPH SIRACUSE

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page. Want to partner? Contact us.

1st Quarter - Report · 2026

Registrant (lobbying firm)

Client

Issues lobbied + lobbyists

TAX — Taxation/Internal Revenue Code

`TAX` — Taxation/Internal Revenue Code